| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/22/2005 | US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics |
| 09/22/2005 | US20050208478 Biological scaffold comprising connective tissue protein for use in identifying angents which delay cutaneous aging |
| 09/22/2005 | US20050208477 Raised surface assay plate |
| 09/22/2005 | US20050208475 Process and apparatus comprising episcopic differential contrast (EDIC) microscopy plus epifluorescence microscopy (EF) for the detection or identification of biological materials on surfaces |
| 09/22/2005 | US20050208474 Method and cell composition for screening compounds for anti-inflammatory activity |
| 09/22/2005 | US20050208473 Device for determining and controlling cell growth and/or growth rate in fermentation reaction |
| 09/22/2005 | US20050208472 Using angiogenesis polypeptide as screening tools iin identifying modulators of for prevention and treatment of cell proliferative disorders; angiogenesis inhibitors |
| 09/22/2005 | US20050208471 Method of characterizing potential therapeutics by determining cell-cell interactions |
| 09/22/2005 | US20050208470 Toll-like receptor assays |
| 09/22/2005 | US20050208468 Assays with primary cells |
| 09/22/2005 | US20050208467 Thin filmed bioreactor comprising coordinate system that supports growth, identification and measurement of cells |
| 09/22/2005 | US20050208463 Method of screening drug |
| 09/22/2005 | US20050208295 Adhesive sheet and kit for microbial testing of solid surface |
| 09/22/2005 | US20050208178 Microbially expressed xylanases and their use as feed additives and other uses |
| 09/22/2005 | US20050208151 Treatment of rheumatoid arthritis with FLIP antagonists |
| 09/22/2005 | US20050208142 Production of nanoparticles having a defined number of ligands |
| 09/22/2005 | US20050208140 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 09/22/2005 | US20050208067 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 09/22/2005 | US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening |
| 09/22/2005 | US20050208062 Compositions and methods relating to hepatic specific genes and proteins |
| 09/22/2005 | US20050208058 For treatment of cell proliferative by modulating/inhibiting centrosomal genes or polypeptides via gene silencing, antibodies, aptamers, ribozymes, and antisense nucleic acids; gene expression inhibition; tubulins |
| 09/22/2005 | US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening |
| 09/22/2005 | US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease |
| 09/22/2005 | US20050208046 TWEAK receptor |
| 09/22/2005 | US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 09/22/2005 | US20050208040 Polynucleotides and polypeptides encoded thereby |
| 09/22/2005 | US20050208030 Myocardial grafts and cellular compositions useful for same |
| 09/22/2005 | US20050208010 Genes from Chromosome 3, 5 and 11 involved in premature canities |
| 09/22/2005 | US20050207981 Compositions and methods for determining substrate specificity of hydrolytic enzymes |
| 09/22/2005 | US20050207943 detectors comprising lasers and optical filters |
| 09/22/2005 | US20050205895 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 09/22/2005 | US20050205840 Oxygen scavenging compositions and methods of use |
| 09/22/2005 | US20050205434 Dna conformational switches as sensitive electronic sensors of analytes |
| 09/22/2005 | US20050205422 Electropolymeric substrate with a surface roughness in the range of 20 nm to 10 microns, a metal electrode, an ultrathin semipermeable membrane and at least one noncovalently immobilized oxidase enzyme membrane; sandwich type set-up; high speed and accuracy; reliable signal amplification |
| 09/22/2005 | DE19721825B4 Verfahren zur Identifizierung von Enterohämorrhagischen E. coli A method for identification of enterohaemorrhagic E. coli |
| 09/22/2005 | DE102004009934A1 Verfahren zur Untersuchung einer Gewebeprobe A method for assaying a tissue sample |
| 09/22/2005 | CA2787367A1 Conformationally flexible cationic conjugated polymers |
| 09/22/2005 | CA2564614A1 Combinatorial interleukin-2 muteins |
| 09/22/2005 | CA2560104A1 Method of measuring glycoprotein |
| 09/22/2005 | CA2559908A1 Method of stabilizing oxidizable color-assuming reagent |
| 09/22/2005 | CA2559555A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome |
| 09/22/2005 | CA2559550A1 Thiol methyltransferase-based selection |
| 09/22/2005 | CA2559390A1 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 09/22/2005 | CA2559095A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
| 09/22/2005 | CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 09/22/2005 | CA2558808A1 Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| 09/22/2005 | CA2558641A1 Artificial mutation controls for diagnostic testing |
| 09/22/2005 | CA2558632A1 Improved interleukin-2 muteins |
| 09/22/2005 | CA2558458A1 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 09/22/2005 | CA2558303A1 Methods and compositions for assessing nucleic acids and alleles |
| 09/22/2005 | CA2558266A1 Reagents, methods and kits for use in deactivating nucleic acids |
| 09/22/2005 | CA2558041A1 Polynucleotides for the detection of escherichia coli o157 |
| 09/22/2005 | CA2557668A1 High efficiency peptide production in plant cells |
| 09/22/2005 | CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 09/22/2005 | CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna |
| 09/22/2005 | CA2557249A1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 09/22/2005 | CA2555541A1 Cd38 splice variant and uses thereof |
| 09/21/2005 | EP1577672A1 Method of analyzing c-terminal amino acid sequence of peptide using mass spectrometry |
| 09/21/2005 | EP1577670A2 Latent reactive polymers with biologically active moieties |
| 09/21/2005 | EP1577669A2 Improved electrochemical biosensor test strip |
| 09/21/2005 | EP1577668A2 Improved elektrochemical biosensor test strip |
| 09/21/2005 | EP1577399A2 Diagnostic kit and method for detecting phytovirus infections in plant production |
| 09/21/2005 | EP1577393A1 PRIMER AND PROBE FOR DETECTING i VIBRIO CHOLERAE /i OR i VIBRIO MIMICUS /i AND DETECTION METHOD USING THE SAME |
| 09/21/2005 | EP1577390A1 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 09/21/2005 | EP1577389A2 Magnetic pigment |
| 09/21/2005 | EP1577387A1 Preventives/remedies for cancer |
| 09/21/2005 | EP1577318A1 Nucleotide derivatives and dna microarray |
| 09/21/2005 | EP1576374A2 Enzyme array and assay |
| 09/21/2005 | EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 09/21/2005 | EP1576369A1 Chemically amplified electrochemical detection of affinity reaction |
| 09/21/2005 | EP1576366A1 Method for determination of free and combined glycerin in biodiesel |
| 09/21/2005 | EP1576352A2 Methods of cardiovascular disease assessment in an individual |
| 09/21/2005 | EP1576349A2 Molecular diagnosis and prognosis of carcinomas |
| 09/21/2005 | EP1576193A1 Assay for rnase h activity |
| 09/21/2005 | EP1576192A2 Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same |
| 09/21/2005 | EP1576191A2 Method for the quantitative assessment of global and specific dna repair capacities of at least one biological medium, and the applications thereof |
| 09/21/2005 | EP1576190A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 09/21/2005 | EP1576189A1 Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device |
| 09/21/2005 | EP1576188A2 Methods for using riboprimers for strand displacement replication of target sequences |
| 09/21/2005 | EP1576187A1 Method for the detection of cancer |
| 09/21/2005 | EP1576186A1 Method for generating a genetically modified organism for screening active substances |
| 09/21/2005 | EP1576185A1 Method for detecting mutations |
| 09/21/2005 | EP1576184A2 Method for the in vitro selection of binders |
| 09/21/2005 | EP1576183A4 Method for correlating gene expression profiles with protein expression profiles |
| 09/21/2005 | EP1576183A2 Method for correlating gene expression profiles with protein expression profiles |
| 09/21/2005 | EP1576181A2 Method for detecting microorganisms |
| 09/21/2005 | EP1576180A2 Ampk pathway components |
| 09/21/2005 | EP1576179A2 Methods and compositions for inducing apoptosis in cancer cells |
| 09/21/2005 | EP1576178A2 Cell proliferation-related polypeptides and uses therefor |
| 09/21/2005 | EP1576177A2 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance |
| 09/21/2005 | EP1576176A2 Short interfering nucleic acid hybrids and methods thereof |
| 09/21/2005 | EP1576175A2 Vascular-preferred promoters |
| 09/21/2005 | EP1576174A2 Methods and compositions for genotyping |
| 09/21/2005 | EP1576173A2 Modulators of cellular proliferation |
| 09/21/2005 | EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2005 | EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use |
| 09/21/2005 | EP1576163A2 High-protein-phenotype-associated plant genes |
| 09/21/2005 | EP1576151A2 Ap1 amine oxidase variants |
| 09/21/2005 | EP1576149A1 Method for the separation of cell fractions |
| 09/21/2005 | EP1576145A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |